1. Home
  2. PLSE vs CVAC Comparison

PLSE vs CVAC Comparison

Compare PLSE & CVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLSE
  • CVAC
  • Stock Information
  • Founded
  • PLSE 2014
  • CVAC 2000
  • Country
  • PLSE United States
  • CVAC Germany
  • Employees
  • PLSE N/A
  • CVAC N/A
  • Industry
  • PLSE Medical/Dental Instruments
  • CVAC Biotechnology: Pharmaceutical Preparations
  • Sector
  • PLSE Health Care
  • CVAC Health Care
  • Exchange
  • PLSE Nasdaq
  • CVAC Nasdaq
  • Market Cap
  • PLSE 1.2B
  • CVAC 1.2B
  • IPO Year
  • PLSE 2016
  • CVAC 2020
  • Fundamental
  • Price
  • PLSE $16.15
  • CVAC $5.31
  • Analyst Decision
  • PLSE Buy
  • CVAC Hold
  • Analyst Count
  • PLSE 1
  • CVAC 3
  • Target Price
  • PLSE $22.00
  • CVAC $6.83
  • AVG Volume (30 Days)
  • PLSE 133.2K
  • CVAC 491.6K
  • Earning Date
  • PLSE 11-05-2025
  • CVAC 11-12-2025
  • Dividend Yield
  • PLSE N/A
  • CVAC N/A
  • EPS Growth
  • PLSE N/A
  • CVAC N/A
  • EPS
  • PLSE N/A
  • CVAC 1.01
  • Revenue
  • PLSE N/A
  • CVAC $599,540,810.00
  • Revenue This Year
  • PLSE N/A
  • CVAC N/A
  • Revenue Next Year
  • PLSE $700.00
  • CVAC $23.40
  • P/E Ratio
  • PLSE N/A
  • CVAC $5.31
  • Revenue Growth
  • PLSE N/A
  • CVAC 675.15
  • 52 Week Low
  • PLSE $13.77
  • CVAC $2.37
  • 52 Week High
  • PLSE $25.00
  • CVAC $5.72
  • Technical
  • Relative Strength Index (RSI)
  • PLSE 37.34
  • CVAC 37.29
  • Support Level
  • PLSE $17.10
  • CVAC $5.33
  • Resistance Level
  • PLSE $18.35
  • CVAC $5.41
  • Average True Range (ATR)
  • PLSE 0.64
  • CVAC 0.04
  • MACD
  • PLSE -0.20
  • CVAC -0.01
  • Stochastic Oscillator
  • PLSE 3.66
  • CVAC 24.00

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

About CVAC CureVac N.V.

CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

Share on Social Networks: